Our Pricing

Buy Wegovy Online UK with Fast Prescription Service

When you buy Wegovy online UK prescription services through Cured Pharmacy, you'll access genuine UK-licensed semaglutide injections from £79.00, with a free clinical consultation completed in under three minutes. Our UK-registered prescribers assess your eligibility the same day, and we deliver discreetly to your door with full GPhC compliance.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone your gut produces after eating. It works by slowing gastric emptying, reducing appetite signals to the brain, and improving insulin sensitivity [1]. This triple mechanism addresses the physiological drivers of weight gain rather than simply suppressing hunger.

In the landmark STEP 1 trial, adults using Wegovy alongside lifestyle modifications achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. Participants also showed improvements in cardiovascular risk markers including blood pressure, HbA1c, and lipid profiles [2].

Wegovy is licensed by the MHRA for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes or hypertension. Your UK prescriber will confirm eligibility during your online consultation based on your medical history and current health status.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a carefully designed dose escalation protocol to minimise gastrointestinal side effects whilst building therapeutic efficacy. You'll start with 0.25 mg once weekly for four weeks, then increase monthly through 0.5 mg, 1 mg, and 1.7 mg, reaching the maintenance dose of 2.4 mg by week 17 [3].

This gradual titration allows your body to adapt to semaglutide's effects on gastric motility and appetite regulation. Most patients notice reduced hunger and smaller portion sizes within the first fortnight, with measurable weight loss typically beginning in weeks 4-8 [3].

Each Wegovy pen is pre-filled for single use and injected subcutaneously into your abdomen, thigh, or upper arm. The injection takes seconds, and the fine needle causes minimal discomfort. Our pharmacist team provides full administration guidance with your first prescription, and you can contact us any time during treatment if questions arise.

Managing Side Effects During Dose Escalation

Nausea, diarrhoea, and constipation are the most commonly reported side effects, particularly during dose increases. These symptoms are usually mild to moderate and resolve within days as your body adjusts [2]. Eating smaller, more frequent meals and avoiding high-fat foods can significantly reduce gastrointestinal discomfort.

If side effects persist or become severe, your prescriber may recommend staying at your current dose for an additional month before escalating. This flexible approach maintains treatment adherence whilst optimising tolerability.

Who Can Use Wegovy: Eligibility Criteria

Wegovy is licensed for weight management in adults with a body mass index of 30 kg/m² or higher, or 27 kg/m² or higher with at least one weight-related health condition such as type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea. NICE guidance supports its use when lifestyle interventions alone have proven insufficient [4].

You cannot use Wegovy if you're pregnant, breastfeeding, or planning pregnancy within the next two months, as semaglutide's effects on foetal development aren't fully established. It's also contraindicated if you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [3].

During your online consultation at Cured Pharmacy, our UK prescribers will review your full medical history, current medications, and weight loss goals. This assessment typically takes under three minutes to complete and determines whether Wegovy is safe and appropriate for your individual circumstances.

Wegovy and Type 2 Diabetes

If you have type 2 diabetes, Wegovy can offer dual benefits: weight reduction and improved glycaemic control. However, it may increase the risk of hypoglycaemia when used alongside insulin or sulfonylureas, so your prescriber may adjust these medications before starting treatment [2].

Regular blood glucose monitoring is essential during the first 12 weeks, and you should report any symptoms of low blood sugar such as tremors, sweating, or confusion to your healthcare team immediately.

Buy Wegovy Online UK Prescription: How Our Service Works

Our streamlined process makes accessing Wegovy straightforward and fully compliant with UK pharmacy regulations. You'll complete a confidential medical questionnaire covering your weight history, previous weight loss attempts, current medications, and relevant health conditions. This takes most patients between two and three minutes.

A UK-registered prescriber from our clinical team reviews your assessment the same day, typically within hours. If Wegovy is deemed safe and appropriate, they'll issue an electronic prescription which our pharmacy dispenses immediately. We source all medications directly from UK-licensed wholesalers, guaranteeing authenticity and proper cold chain storage for temperature-sensitive biologics like semaglutide.

Your Wegovy pens arrive in discreet, unmarked packaging via tracked courier, usually within 24-48 hours for mainland UK addresses. Each delivery includes full patient information leaflets, injection technique guidance, and direct contact details for our pharmacist team should you need support during treatment.

Wegovy Pricing and Ongoing Treatment Costs

Wegovy is available at Cured Pharmacy from £79.00 per month, with transparent pricing displayed before you begin your consultation. This includes your medication, clinical assessment, prescription, and delivery with no hidden fees or subscription charges.

Weight loss treatment with Wegovy is most effective when maintained for at least 12-18 months, as clinical trials demonstrate continued weight reduction throughout this period [1]. After reaching your target weight, your prescriber will discuss whether to continue at the maintenance dose or transition to a structured discontinuation plan to preserve your results.

We never require upfront payment for multiple months. You'll pay monthly as you progress through treatment, giving you full flexibility to pause or stop if your circumstances change. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), personally oversees all prescribing decisions to ensure every patient receives individualised care aligned with NICE and MHRA guidance.

Comparing Wegovy Costs Across UK Pharmacies

Wegovy pricing varies significantly across UK online pharmacies, with monthly costs ranging from competitive rates to premium pricing depending on service model and supply arrangements. At Cured Pharmacy, our lowest price guarantee ensures you're accessing the most cost-effective legitimate source without compromising on clinical safety or medication authenticity.

Be cautious of significantly below-market pricing, which may indicate non-UK sourced medication, inadequate prescriber oversight, or compromised storage conditions. All GLP-1 medications require refrigeration until first use, and any pharmacy offering Wegovy without proper cold chain logistics risks dispensing degraded product with reduced efficacy.

Wegovy Weight Loss Results: What Clinical Trials Show

The STEP clinical trial programme provides robust evidence for Wegovy's efficacy across diverse patient populations. In STEP 1, participants without diabetes lost an average 14.9% of their baseline body weight over 68 weeks, with 50.5% achieving at least 15% weight reduction and 32% losing 20% or more [1].

STEP 2 specifically examined patients with type 2 diabetes, demonstrating an average 9.6% weight loss alongside significant HbA1c improvements of 1.6 percentage points [5]. These results exceeded those seen with other weight management medications and approached outcomes previously only achievable through bariatric surgery.

Individual results vary based on adherence, baseline metabolic health, lifestyle modifications, and genetic factors affecting GLP-1 receptor sensitivity. Your prescriber will set realistic expectations during your consultation and recommend evidence-based dietary and activity strategies to optimise your response to treatment [4].

Maintaining Weight Loss After Wegovy

The STEP 4 trial examined what happens when patients discontinue Wegovy after 20 weeks of treatment. Those who stopped the medication regained approximately two-thirds of their lost weight over the following year, whilst those who continued maintained their weight reduction [6].

This data underscores that Wegovy treats the biological mechanisms driving obesity rather than curing the condition. Long-term weight management requires ongoing treatment combined with sustainable lifestyle changes, and your clinical team will support you in developing strategies to preserve your results whether you continue medication or transition to maintenance without pharmacotherapy.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance [TA875]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta875
5. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0
6. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.